GLOBAL SMART INHALERS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • GLOBAL SMART INHALERS MARKET FORECAST 2019-2028

GLOBAL SMART INHALERS MARKET FORECAST 2019-2028

The global smart inhalers market is anticipated to grow at a CAGR of 31.66% between 2019 and 2028, and is anticipated to generate revenue of $522181 thousand by 2028. Smart inhalers are the devices that are used for delivering a variety of medication through inhalation. Smart inhalers have proved to increase the adherence rate in patients suffering from asthma and COPD. The high prevalence of chronic respiratory diseases and the growing prevalence of COPD and asthma are the dominant factors impacting the growth of the market.

GLOBAL SMART INHALERS MARKET FORECAST 2019-2028

Global Smart Inhalers Market by Product (Smart Inhalers, Smart Nebulizer (Types of Nebulizer (Qualitative), Nebulizer by Portability (Qualitative), Nebulizer by Sales Channel (Qualitative))) by Indication (Asthma, Copd) by Distribution Channel (Hospital, Pharmacy) and by Geography.

Request free sample

The global smart inhalers market is anticipated to grow at a CAGR of 31.66% between 2019 and 2028, and is anticipated to generate revenue of $522181 thousand by 2028. Smart inhalers are the devices that are used for delivering a variety of medication through inhalation. Smart inhalers have proved to increase the adherence rate in patients suffering from asthma and COPD.

Key factors propelling the global smart inhalers market growth:

  • Rise in air pollution
  • High prevalence of chronic respiratory diseases
  • Surging indoor air pollutants
  • Rising geriatric population
  • Growing prevalence of COPD and asthma

Global Smart Inhalers Market

To know more about this report, request a free sample copy

The high prevalence of chronic respiratory diseases and the growing prevalence of COPD and asthma are the dominant factors impacting the growth of the market. Chronic respiratory diseases are diseases that affect the airways and other parts of the lungs. Tobacco smoking is one of the primary causes of the increase of respiratory diseases, across the world. This rising respiratory disease is anticipated to drive the market growth. A rise in cases of both COPD and asthma is anticipated to lead to an increase in the adoption of smart inhalers, due to the need for better treatment.

In 2019, around 94.49% of the revenue share was captured by the smart inhalers category in the product segment. In the same segment, the smart nebulizer is anticipated to be the fastest-growing product. The smart inhalers segment is further segregated into dry powder inhalers and metered dose inhalers. They are small handheld devices that are used to deliver drugs orally for the treatment of COPD and asthma through the lungs. Metered-dose inhaler (MDI) is the most widely used old devices for aerosol therapy. Smart Nebulizers are either electric-or battery-powered machines that turn liquid asthma medication into gas or mist, which is inhaled by the patient.

The data security concern and high cost of asthma and COPD treatment are the major factors hampering the growth of the smart inhalers market. As smart inhalers are wirelessly connected and track patient’s data, the risk of the data breach and misuse of the data is high. A sudden attack of asthma requires rescue inhalers, which are not readily available in low-income countries due to high cost.

The report scope of the global smart inhalers market includes the segmentation analysis of product, indication, and distribution channel.

Product is segmented into:

  • Smart Inhalers
    • Dry powder inhaler
    • Metered-dose inhaler
  • Smart nebulizer

Indication is segmented into:

  • Asthma
  • COPD

Distribution Channel is segmented into:

  • Hospital
  • Pharmacy

Geographically, the global smart inhalers market has been segmented based on four major regions, which includes:

  • North America: the United States and Canada
  • Asia Pacific: India, China, Japan, South Korea, Indonesia, Thailand Vietnam, Australia & New Zealand, and Rest of Asia Pacific
  • Europe: Germany, the United Kingdom, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Rest of World: Latin America, the Middle East & Africa

In terms of geography, North America dominated the market with a revenue share of approx. 38.84% in 2019. The United States dominated the North America market in 2019, owing to an increasing prevalence of respiratory diseases, thereby driving the demand for smart inhalers. The driving factors for the North American market include the availability of advanced technology, affordability, along with the rising awareness regarding the benefits of patient monitoring devices. The other factors that contribute to the market growth are the growing geriatric population, and the increasing incidence of various lifestyle-related diseases.

The region of Asia Pacific is projected to record the highest growth rate by the end of the forecast period. China and India are the fastest developing economies in the Asia Pacific region with a huge population, which will result in growth opportunities for the market under study. The mortality and morbidity from COPD in China may upsurge exponentially in the upcoming years, driven in part by the elderly population, and continual growth in smoking rates, especially in women.

The major players of the global smart inhalers market are:

  • Adherium Limited
  • Boehringer Ingelheim GmbH
  • Glaxosmithkline Plc
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Others

Key strategies adopted by some of the smart inhalers companies:

In March 2020, The BrandLab (TBL) and 3M and announced a two-year enterprise (2020 and 2021) fixated on driving diversity within imaginative career paths, including industrial and graphic design. In April 2020, the U.S. government and Philips collaborated in ventilator production ramp-up to combat the COVID-19 pandemic.

Key findings of the global smart inhalers market:

  • There is an increasing demand for home healthcare devices.
  • Mesh nebulizer is being adopted on a large scale.
  • There is an improvement in the adherence rate.
  • Asthma is the highest revenue-generating indication segment.
  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISE IN AIR POLLUTION
      • HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
      • SURGING INDOOR AIR POLLUTANTS
      • RISING GERIATRIC POPULATION
      • GROWING PREVALENCE OF COPD AND ASTHMA
    •    KEY RESTRAINTS
      • DATA SECURITY CONCERN HAMPERS THE MARKET
      • HIGH COST OF ASTHMA AND COPD TREATMENT
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • EVOLUTION OF SMART INHALERS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY PRODUCT
    •    SMART INHALERS
      • DRY POWDER INHALER
      • METERED DOSE INHALER
    •    SMART NEBULIZER
      •    TYPES OF NEBULIZER (QUALITATIVE)
        • PNEUMATIC NEBULIZER
        • ULTRASONIC NEBULIZER
        • MESH NEBULIZER
      •    NEBULIZER BY PORTABILITY (QUALITATIVE)
        • TABLETOP NEBULIZER
        • PORTABLE NEBULIZER
      •    NEBULIZER BY SALES CHANNEL (QUALITATIVE)
        • DIRECT PURCHASE
        • ONLINE PURCHASE
  1. MARKET BY INDICATION
    • ASTHMA
    • COPD
  2. MARKET BY DISTRIBUTION CHANNEL
    • HOSPITAL
    • PHARMACY
  3. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    •    ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPANY PROFILES
    • 3M COMPANY
    • ADHERIUM LIMITED
    • AGILENT TECHNOLOGIES INC
    • ASTRAZENECA PLC
    • BOEHRINGER INGELHEIM GMBH
    • COHERO HEALTH INC
    • GLAXOSMITHKLINE PLC
    • KONINKLIJKE PHILIPS N.V
    • NOVARTIS AG
    • OPKO HEALTH INC
    • RESMED INC (PROPELLER HEALTH)
    • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    • VECTURA GROUP PLC

TABLE LIST

TABLE 1: MARKET SNAPSHOT – SMART INHALERS

TABLE 2: GLOBAL SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 3: GLOBAL SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 4: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 5: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 6: GLOBAL SMART INHALERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 7: GLOBAL SMART INHALERS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 8: GLOBAL SMART NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 9: GLOBAL SMART NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 10: GLOBAL SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 11: GLOBAL SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 12: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 13: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 14: GLOBAL COPD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 15: GLOBAL COPD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 16: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 17: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 19: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 20: GLOBAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 21: GLOBAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 22: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 23: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 24: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 25: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 26: EUROPE SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 27: EUROPE SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 28: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 29: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 30: REST OF WORLD SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 31: REST OF WORLD SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

FIGURE LIST

FIGURE 1: GLOBAL POPULATION, BY AGE GROUP 2015 & 2020 (IN MILLION)

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: GLOBAL SMART INHALERS MARKET, BY PRODUCT, IN 2019

FIGURE 7: GLOBAL SMART INHALERS MARKET, BY SMART INHALERS, 2019-2028 (IN $ THOUSAND)

FIGURE 8: GLOBAL SMART INHALERS MARKET, BY DRY POWDER INHALER, 2019-2028 (IN $ THOUSAND)

FIGURE 9: GLOBAL SMART INHALERS MARKET, BY METERED DOSE INHALER, 2019-2028 (IN $ THOUSAND)

FIGURE 10: GLOBAL SMART INHALERS MARKET, BY SMART NEBULIZER, 2019-2028 (IN $ THOUSAND)

FIGURE 11: GLOBAL SMART INHALERS MARKET, BY INDICATION, IN 2019

FIGURE 12: GLOBAL SMART INHALERS MARKET, BY ASTHMA, 2019-2028 (IN $ THOUSAND)

FIGURE 13: GLOBAL SMART INHALERS MARKET, BY COPD, 2019-2028 (IN $ THOUSAND)

FIGURE 14: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 15: GLOBAL SMART INHALERS MARKET, BY HOSPITAL, 2019-2028 (IN $ THOUSAND)

FIGURE 16: GLOBAL SMART INHALERS MARKET, BY PHARMACY, 2019-2028 (IN $ THOUSAND)

FIGURE 17: NORTH AMERICA SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 18: THE UNITED STATES SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 19: CANADA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 20: EUROPE SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 21: GERMANY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 22: FRANCE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 23: THE UNITED KINGDOM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 24: ITALY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 25: RUSSIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 26: BELGIUM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 27: POLAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 28: REST OF EUROPE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 29: ASIA PACIFIC SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 30: JAPAN SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 31: CHINA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 32: INDIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 33: AUSTRALIA & NEW ZEALAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 34: SOUTH KOREA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 35: THAILAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 36: INDONESIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 37: VIETNAM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 38: REST OF ASIA PACIFIC SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 39: REST OF WORLD SMART INHALERS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 40: LATIN AMERICA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 41: MIDDLE EAST & AFRICA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

  1. MARKET BY PRODUCT
    •    SMART INHALERS
      • DRY POWDER INHALER
      • METERED DOSE INHALER
    •    SMART NEBULIZER
      •    TYPES OF NEBULIZER (QUALITATIVE)
        • PNEUMATIC NEBULIZER
        • ULTRASONIC NEBULIZER
        • MESH NEBULIZER
      •    NEBULIZER BY PORTABILITY (QUALITATIVE)
        • TABLETOP NEBULIZER
        • PORTABLE NEBULIZER
      •    NEBULIZER BY SALES CHANNEL (QUALITATIVE)
        • DIRECT PURCHASE
        • ONLINE PURCHASE
  1. MARKET BY INDICATION
    • ASTHMA
    • COPD
  2. MARKET BY DISTRIBUTION CHANNEL
    • HOSPITAL
    • PHARMACY
  3. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    •    ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    •    REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now